2 ms·
The reason I asked is because this sounds like non-news. Like wasn't this the main benefit listed in the pharmaceutical review - reduction in vascular events/mo
by giantg2 3y ago
The reason I asked is because this sounds like non-news. Like wasn't this the main benefit listed in the pharmaceutical review - reduction in vascular events/mortality by reducing weight? I was wondering if this was new research that showed an additional 20% reduction in groups with similar weight loss.
- alistairSH 3y agoI think the "heart condition" language is now explicit. The previous FDA approval[1] was for "management of obesity and at least one weight-treated condition" 1 - https://www.fda.gov/news-events/press-announcements/fda-approves-new-drug-treatment-chronic-weight-management-first-2014 https://www.fda.gov/news-events/press-announcements/fda-appr...